InvestSMART

Imricor Medical Systems Inc (ASX: IMR) - Announcements

- Current share price for IMR : $1.810

ASX company news and announcements for Imricor Medical Systems Inc (IMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imricor Medical Systems Inc (IMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imricor Medical Systems Inc (IMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imricor Medical Systems Inc (IMR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$649 Imricor's Products to Operate with GE Healthcare MRI Systems 24 Apr 2023 9:30AM $0.330 $1.810 risen by 448.48%
$649 Notification of cessation of securities - IMR 14 Apr 2023 10:47AM $0.290 $1.810 risen by 524.14%
$649 Business Update - Correction 13 Apr 2023 2:46PM $0.300 $1.810 risen by 503.33%
$649 Business Update 13 Apr 2023 9:44AM $0.295 $1.810 risen by 513.56%
$649 Imricor Establishes First iCMR Site in Switzerland 11 Apr 2023 9:28AM $0.290 $1.810 risen by 524.14%
$649 Letter to Shareholders and Online Meeting Guide 6 Apr 2023 9:15AM $0.290 $1.810 risen by 524.14%
$649 Notice of Annual Stockholders Meeting and CDI Voting Form 6 Apr 2023 9:12AM $0.290 $1.810 risen by 524.14%
$649 Appendix 4G and Corporate Governance Statement 6 Apr 2023 9:09AM $0.290 $1.810 risen by 524.14%
$649 Annual Report to shareholders 6 Apr 2023 9:08AM $0.290 $1.810 risen by 524.14%
$649 Notification regarding unquoted securities - IMR 29 Mar 2023 10:55AM $0.305 $1.810 risen by 493.44%
$649 Cleansing Notice - Convertible Note Tranche 2 29 Mar 2023 9:42AM $0.305 $1.810 risen by 493.44%
$649 Appendix 3B - Tranche 2 Convertible Note and Warrants 29 Mar 2023 9:36AM $0.305 $1.810 risen by 493.44%
$649 Appendix 3Y - MT 17 Mar 2023 1:58PM $0.340 $1.810 risen by 432.35%
$649 NWR Virtual Healthcare Conference 15 Mar 2023 10:48AM $0.340 $1.810 risen by 432.35%
$649 Appendix3Y - MT 13 Mar 2023 8:38AM $0.330 $1.810 risen by 448.48%
$649 Appendix 3Y - SW 7 Mar 2023 10:49AM $0.340 $1.810 risen by 432.35%
$649 Results of Meeting 7 Mar 2023 10:48AM $0.340 $1.810 risen by 432.35%
$649 FY22 Results Investor Presentation 23 Feb 2023 8:48AM $0.320 $1.810 risen by 465.63%
$649 Imricor Releases FY22 Results 23 Feb 2023 8:48AM $0.320 $1.810 risen by 465.63%
$649 Appendix 4E and FY22 Financial Accounts 23 Feb 2023 8:46AM $0.320 $1.810 risen by 465.63%
$649 Online Meeting Guide 15 Feb 2023 9:35AM $0.300 $1.810 risen by 503.33%
$649 Notice of Extraordinary General Meeting/Proxy Form 13 Feb 2023 2:30PM $0.295 $1.810 risen by 513.56%
$649 Ceasing to be a substantial holder 13 Feb 2023 8:08AM $0.290 $1.810 risen by 524.14%
$649 FY22 Results Webinar 8 Feb 2023 9:56AM $0.190 $1.810 risen by 852.63%
$649 Change in substantial holding 7 Feb 2023 8:19AM $0.190 $1.810 risen by 852.63%

301 - 325 of 600 results

Page 13 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.